title: New anomalies due to methotrexate and misoprostol exposure in early pregnancy.
authors.affiliation: Department of Family Practice, University of British Columbia, Vancouver, Canada.
authors.forename: Kate
authors.initials: K
authors.lastname: MacDonald
authors.forename: Wendy V
authors.initials: WV
authors.lastname: Norman
authors.forename: Oana
authors.initials: O
authors.lastname: Popescu
mesh_terms: D000015:Abnormalities, Multiple / Q000139:chemically induced*; D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage / Q000009:adverse effects*; D000028:Abortion, Induced / Q000009:adverse effects; D000293:Adolescent; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D016595:Misoprostol / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol; D008727:Methotrexate
keywords: Canada; Case report; Medical abortion; Methotrexate; Misoprostol; Teratogen